INTRODUCTION: Embryonic development and tissue homeostasis depend on cooperation between specialized cell types. Resident macrophages are professional phagocytes that survey their surroundings; eliminate unfit cells, microorganisms, and metabolic waste; and produce a large range of bioactive molecules and growth factors. Resident macrophages also serve tissuespecific purposes: For example, microglia in the central nervous system support neuronal circuit development, Kupffer cells scavenge blood particles and dying red blood cells in the liver, and alveolar macrophages uptake surfactant and remove airborne pollutants and microbes from the airways. Resident macrophage diversity in adult mice is reflected in tissue-specific gene expression profiles, which may be due to responses to specific cues from their microenvironment, different developmental processes, and the contribution of distinct progenitors cell types. Altogether, the mechanisms responsible for the generation of tissue-resident macrophage diversity remain unclear.
RATIONALE: Tissue-resident macrophages originate, at least in part, from mesodermal erythro-myeloid progenitors (EMPs) from the yolk sac, which invade the embryo proper at the onset of organogenesis. These tissue-resident macrophages are also self-maintained in postnatal tissues, independently of definitive hematopoietic stem cells (HSCs) in a steady state. We therefore hypothesized that resident macrophages represent a founding cell type within most organ anlagen. In this model, the generation of macrophage diversity, as observed in the tissues of postnatal mice, may be integral to organogenesis.
RESULTS:
To test this hypothesis and explore the molecular basis of macrophage diversity in mammals, we performed a spatiotemporal analysis of macrophage development in mice, from embryonic day 9 (E9) to 3 weeks after birth. Unbiased single-cell RNA sequencing (RNA-seq) analysis of CD45 + cells, combined with RNA-seq analyses of sorted cell populations, genetic fate mapping, and in situ analyses, revealed that EMPs give rise to a population of premacrophages (pMacs) that colonize the whole embryo from E9.5, as they acquire a core macrophage differentiation program that includes pattern recognition, scavengers, and cytokine receptors. The chemokine receptor Cx3cr1 is upregulated in pMacs and is important for embryo colonization, which is delayed in Cx3cr1-deficient embryos. Fate mapping of pMacs using a Tnfrsf11a-Cre reporter labels homogeneously fetal and adult tissue-resident macrophages but not HSCs and their progeny. Transcriptional regulators that identify postnatal tissue-resident macrophages in the brain, liver, kidney, skin, and lung were specifically up-regulated immediately after colonization. These dynamic changes mark the onset of diversification into adult macrophages. We identified Id3 as a Kupffer cell-specific transcriptional regulator. Deletion of Id3 in pMacs resulted in Kupffer cell deficiency but did not affect development of microglia and kidney macrophages.
CONCLUSION: Our study shows that EMPderived precursors colonize embryonic tissues and simultaneously acquire a full core macrophage program. This is followed by their diversification into tissue-specific macrophages during organogenesis, likely via the expression of distinct sets of transcriptional regulators. These results indicate that differentiation of tissue-resident macrophages is an integral part of organogenesis and identify a spatiotemporal molecular road map for the generation of macrophage diversity in vivo. Our findings provide a conceptual framework to analyze and understand the consequence(s) of genetic variation for macrophage contribution to development, homeostasis, and disease pathogenesis in different tissues and will support efforts to differentiate specialized macrophages in vitro.
T issue-resident macrophages are a diverse family of cells found in most organs. They include brain microglia, liver Kupffer cells, lung alveolar macrophages, and epidermal Langerhans cells. In mice, tissue-resident macrophages share an embryonic origin and differentiate, at least in part, from yolk sac (YS) erythro-myeloid progenitors (EMPs) (1, 2) . Tissueresident macrophages are also self-maintained in adult tissues, independently of hematopoietic stem cells (HSCs) under steady-state conditions (3) (4) (5) (6) . However, the mechanisms responsible for the generation of macrophage diversity observed in adult mice remain unclear. It has been proposed that resident macrophage diversity reflects their exposure to specialized tissue environments (7) (8) (9) (10) or the contribution of distinct embryonic or fetal progenitors to distinct subsets (2, (11) (12) (13) .
The preferential expression of transcription factors in macrophage subsets was also noted (7) and appears functionally important. Several such cases-including Gata6 for large peritoneal macrophages (9, 10, 14) , Runx3 for Langerhans cells (15) , Nr1h3 for splenic marginal zone macrophages (16) , SpiC for splenic red pulp macrophages (17) , and Pparg for alveolar macrophages (18)-have been functionally validated by knockout mice. To better understand how macrophage diversity is generated, we performed a molecular and spatiotemporal analysis of macrophage development in mice.
Colonization of developing tissues by EMP-derived macrophage precursors
Erythro-myeloid progenitors (Csf1r + Kit + CD45 low AA4.1 + ) are first detected in the YS at embryonic day 8.5 (E8.5) (2, 19) and subsequently colonize the fetal liver (1, 2). Previous fate-mapping analysis of EMP differentiation indicated that their progeny lose Kit expression and increase CD45 expression as they invade the embryo before acquiring F4/80 expression to give rise to fetal and postnatal tissue-resident macrophages (2) (Fig. 1A) . To explore the spatiotemporal and molecular determinants of macrophage differentiation and diversification, we first performed whole-transcriptome sequencing of sorted CD45 1D and fig. S2 ). Overlay of EMP, pMac, and macrophage signatures from differentially expressed genes in bulk RNA-seq analysis (table S2) indicated superimposition on clusters 1, 2, and 3, respectively (Fig. 1E ). Intermediate differentiation states in EMPs, pMacs, and macrophages were clearly apparent, which suggests a gradual differentiation path from EMPs to macrophages via pMacs (Fig. 1E) , consistent with the scorecard analysis.
Core macrophage transcriptional program
Analysis of genes differentially expressed in EMPs, pMacs, and early macrophages by scRNAseq (Figs. 1F and 2A and table S2) (Fig. 3B and fig. S4 ).
Detection of the early expression of the cytokine receptor Tnfrsf11a in pMacs by RNA-seq and scRNA-seq analyses (Figs. 2B and 3C) Fig. 3D and fig. S5 ). Fetal macrophages in all tissues also expressed YFP at comparable levels at E10.25 and E14.5 (Fig. 3D) . In addition,~80% of brain, lung, epidermis, kidney, and liver macrophages from 6-week-old mice expressed YFP (Fig. 3D) . Therefore, the whole resident macrophage lineage is labeled in Tnfrsf11a
Cre ; Rosa26 LSL-YFP mice, although Tnfrsf11a expression itself is lost in postnatal Langerhans cells and alveolar macrophages (Fig. 2B) . Moreover, we noted that YFP expression was observed in only~15% of fetal HSCs, adult HSCs, and HSC-derived cells in the blood and tissues of adult mice (Fig. 3D and fig. S5 A progressive enrichment of pMac-and macrophage-specific gene expression signatures was observed in gene set enrichment analysis (GSEA) of bulk RNA-seq data ( fig. S7, A  and B) . Moreover, the core macrophage signature identified in adult mice by the Immunological Genome Consortium (25) was already enriched in the genes up-regulated in pMacs and early macrophages compared with EMPs ( fig. S7, C and D) . In silico investigation of transcription factor binding sites identified using chromatin immunoprecipitation sequencing (ChIP-seq) in the proximity of up-regulated genes [transcription start site (TSS) ± 20 kb] in pMacs and macrophages further supports the proposition that pMacs undergo a coordinated macrophage differentiation program: A Locus Overlap Analysis (LOLA) (26) yielded a statistically significant association (adjusted P ≤ 0.001, Benjamini Yekutieli correction) with binding sites for Spi1, Egr1, Irf1, Irf8, Maf, Jun, Stat1, Stat3, Stat5b, Stat6, Rela, and Relb ( fig. S8A ). These factors are expressed in our data set (fig. S8B and tables S1 and S5), and their binding sites align at the same loci in enhancers and superenhancers associated with differentially regulated genes such as thrombospondin1 (Thbs1) (27) , Cx3cr1 (8), F4/ 80 (Emr1), and Mrc1 but not with control genes such as Gata1 and MyoD ( fig. S8C ). Comparable results, with a higher statistical significance, were found for genes differentially up-regulated in early macrophages when compared with EMPs ( fig. S8A ).
Together, these results characterize, at the cellular and molecular level, the EMP-derived macrophage precursors (pMacs) that acquire a core macrophage transcriptional program as they colonize the head and caudal embryo from E9.5 in a Cx3cr1-dependent manner to give rise to tissue-resident macrophages. These data are consistent with our previous demonstration that the vast majority of resident macrophages in these tissues originate from a progenitor that does not express the stem cell and endothelial marker Tie2 after E10.5 (2). However, our results do not exclude the possibility that later precursors may also contribute to the resident macrophage pool. Supervised analyses identified lists of genes differentially up-regulated in each cell population (table S3 and fig. S9 , B and C). The signatures of adult tissue-resident macrophages of the brain, lung, and liver previously defined by independent research (7, 25, 28) were progressively enriched in our developing resident macrophage populations (fig. S10, A to D). Finally, scorecard (21) and GSEA analysis of differentially upregulated genes for each postnatal macrophage population in all tissues and over time from E9 to P21 (Fig. 5 , B and C, and fig. S10C ) revealed that the tissue-specific signature of postnatal microglia, Kupffer cells, and kidney macrophages could be traced back to fetal macrophages as early as E12.5 (Fig. 5B ). The signatures of Langerhans cells and alveolar macrophages reflected important postnatal changes in gene expression (Fig. 5C) , noted in previous studies (29) , which may reflect their anatomical location at epithelial barriers.
Early specification of tissue-resident macrophages
Tissue-specific sets of transcriptional regulators define macrophage diversity A heat-map visualization of all transcriptional regulators present in the postnatal tissue-specific signatures (twofold change, adj. P < 0.05, BH correction, Fig. 5D ) confirmed the tissue-specific expression of the transcription factors Sall1 and Sall3 in microglia (7), Nr1h3 (Lxra) in Kupffer cells (30) , Pparg in lung alveolar macrophages (18, 31) , and Runx3 and Ahr in Langerhans cells (15, 32) (Fig. 5D ) and identified additional tissuespecific transcriptional regulators such as Id1 and Id3 in Kupffer cells (Fig. 5D ). In addition, this analysis showed that many of these transcriptional regulators start to be differentially expressed in tissue macrophages as early as E10.25-for example, in Sall1 and Sall3 in head macrophages; Nr1h3, Id1, and Id3 in the liver; and Ahr in limb macrophages (Fig. 5D ). Some genes, like Id1 and Sall3, are expressed by progenitors and pMacs before their expression becomes restricted to macrophages in the liver and the head, respectively ( fig. S10E ), whereas expression of other genes, such as Id3 and Sall1, is low in progenitors and up-regulated in pMacs ( fig. S10E ). In situ immunofluorescence confirmed expression of Id3 by E10.25 macrophages in the liver and head and of Id1 in liver macrophages (Fig. 6A ). Together these data suggest that the transcriptional programs of tissue-specific resident macrophages start to be established early on, as soon as macrophages or pMacs are present in tissues, and identify a number of "candidate" tissue-specific transcriptional regulators. We thus investigated whether specification of tissue macrophages takes place in F4/80 + macrophages or at the level of their pMac or EMP precursors. We plotted transcriptional coexpression of Id1, Id3, and Sall3 onto the tdistributed stochastic neighbor embedding (tSNE) representation of single CD45 low/+ cells from our scRNA-seq data set (Figs. 1D and 6B and fig. S11 ). Coexpression of Id1 and Id3 was found in pMacs and macrophages. However, Id1 and Sall3 were coexpressed in EMPs and pMacs, and Id3 and Sall3 were coexpressed in pMacs, suggesting that cells at the pMac state are not completely committed to exclusive expression of tissue-specific transcription factors. These data confirmed that Id1 and Sall3 are expressed by progenitors and pMacs ( fig. S10E ), although their expression is ultimately lost by tissue macrophages outside the liver and the brain, respectively (Figs. 5D  and 6B and fig. S10E ). When common and tissuespecific E14.5 to E18.5 macrophage signatures (table S2) were superimposed on the pMac population, we found that the common macrophage signature was expressed in pMacs with a gradual enrichment within this population (Fig. 6C) . However, we did not observe pMac subsets expressing tissue-specific signatures (Fig. 6C) . The lack of tissue specificity within pMacs was confirmed using an alternative bioinformatic approach based on analysis of multimodal expression followed by hierarchical clustering of genes with subsequent analysis of enrichment of tissue signatures within these clusters in pMacs ( fig. S11E) .
Taken together, these data suggest that expression of Id1 and Id3 or Sall3 does not specify pMac subsets precommitted to give rise to either Kupffer cells or microglia. More generally, diversification of tissue macrophages appears to take place after pMacs have colonized tissues and differentiated into F4/80 + macrophages.
The transcriptional regulator Id3 is essential for Kupffer cell development
To functionally validate the role of early tissuespecific transcriptional regulators on the development and specification of tissue macrophages-and, thereby, to validate the importance of our findingswe studied the role of Id3 expression in Kupffer cell differentiation. E10.25 Id3-deficient embryos had normal or increased numbers of pMacs and early macrophages in the YS, but macrophages were reduced in numbers in the embryo proper (liver and head) in comparison with littermate controls (Fig. 7A) . The further development of liver macrophages was severely impaired in E14.5 and E18.5 Id3-deficient embryos, as determined by flow cytometry and histology, and 4-weekold Id3-deficient mice still presented with a marked Kupffer cell deficiency, whereas development of microglia and kidney macrophages appeared normal (Fig. 7 , B, C, and E, and fig.  S12C ). The role of Id3 in Kupffer cells appears to be cell-autonomous, as targeted deletion of an Id3 floxed allele in pMacs (Tnfrsf11a
f/f ) recapitulated the phenotype of the Id3-deficient mice in embryo and postnatal mice (Fig. 7, C and D mice pulse-labeled with OH-TAM at E8.5 ( Fig. 7F  and fig. S12B ). In contrast, fate-mapped microglia do not express Id3 (fig. S12B ), in line with our RNA-seq data (Fig. 5D ). Of note, the partial Kupffer cell deficiency observed in Id3-deficient and Tnfrsf11a
Cre+ ; Id3 f/f embryos and adults was not associated with an abnormal liver lobular architecture or vasculature (Fig. 7, C and D, and  fig. S12D ). Kupffer cell proliferation in the steady state was not affected by Id3 deficiency (Fig.  7G) data, therefore, suggest that a broad or core macrophage program is progressively restricted or refined to a tissue-specific one in response to the absence and presence of tissue-specific cues, rather than the alternative possibility that committed subsets of early macrophages, pMacs, or even EMPs choose their future tissue of residence.
The present results are consistent with an EMP origin of tissue-resident macrophages (2), although they do not exclude the additional contribution of primitive precursors (23), fetal HSCs, or a second wave of EMPs (11, 12) , which would adopt a similar differentiation program when entering tissues. However, the transcriptional data set described here may lead to reinterpretation of fate-mapping models used to characterize the contribution of such later waves. For example, the progressive YFP expression by fetal macrophages in S100a4
Cre ; Rosa26 LSL-YFP mice (12) is compatible with our present findings and does not require the existence of a second wave of precursors because expression of S100a4 and several other S100a family members was found to be part of the pMac transcriptional profile ( fig. S13) .
We propose that establishment of a core macrophage differentiation program in EMP-derived pMacs, as they colonize the embryo, is followed by the initiation of macrophage specification via the acquisition of tissue-specific transcriptional regulators, such as Id3 in Kupffer cells. This process is initiated simultaneously in the whole embryo during the first 2 days of organogenesis, from E8.5 to E10.5. Differentiation of resident macrophages is thus a developmental process and an integral part of organogenesis, independent of postnatal changes in the environment in the kidney, liver, and brain but not in the skin or lung. These results also identify a developmental window where the molecular mechanisms of macrophage specification can best be studied, tools to selectively label resident macrophages, and sets of tissue-specific transcriptional regulators expressed by developing and adult macrophages that may control their differentiation, maintenance, and function. Additionally, our results elucidate a molecular road map that will support efforts to differentiate specialized macrophages-microglia, Kupffer cells, kidney macrophages, alveolar macrophages, and Langerhans cells-in vitro from multipotent progenitors. Finally, our work provides a framework to analyze and understand the consequence(s) of genetic variation for macrophage contribution to disease pathogenesis in different tissues. 
Materials and methods Mice

Preparation of cell suspensions and cell sorting
Pregnant females were killed by cervical dislocation or by exposure to CO 2 . Embryos ranging from E9 to E18.5 were removed from the uterus, washed in 4°C phosphate-buffered saline (PBS, Invitrogen) and dissected under a Leica M80 microscope. Yolk sacs (YS) were harvested from embryos between E9 and E10.5. To obtain singlecell suspensions for FACS sorting, tissues were included in cold PBS and mechanically disrupted under a 100um filter. Postnatal tissues were collected following the same procedure. For collection of Langerhans cells, epidermal sheets (from E18.5 to P21) were separated from the dermis after incubation for 45 min at RT in 4.8 mg/ml of dispase (Invitrogen), 3% fetal calf serum (FCS, Invitrogen) and 1 mM of flavopiridol (Sigma). The epidermis was further digested for 30 min at RT in PBS containing 2 mg/ml of collagenase D (Roche), 200 U/ml DNase I (Sigma), 4.8 mg/ml of dispase (Invitrogen), 3% FCS (Invitrogen) and 1uM of flavopiridol (Sigma) followed by mechanical disruption under a 100um filter. For blood phenotyping, mice were anaesthetized and blood was collected by cardiac puncture. For flow cytometry experiments, organs were incubated in PBS containing 1 mg/ml collagenase D (Roche), 100 U/ml DNase I (Sigma), 2.4 mg/ml of dispase (Invitrogen) and 3% FCS (Invitrogen) at 37°C for 30 min prior to mechanical disruption. Epidermal sheets were obtained as previously described (2) . For embryonic tissue incubation time at 37°C was reduced to 20 min. Cell suspensions were centrifuged at 320g for 7 min, resuspended in FACS buffer (PBS, 0.5% BSA and 2 mm EDTA) containing purified anti-CD16/32 (FccRIII/II) (1:100 dilution) and incubated for 15 min at 4°C. Samples were immunostained with antibodies mixes for 30 min at 4°C, and analyzed by flow cytometry using a LSR Fortessa X-20 (BD-Bioscience). Single live cells were gated on the basis of dead cell exclusion (Hoechst 33258), side (SSC-A) and forward scatter (FSC-A) gating, and doublet exclusion using forward scatter width (FSC-W) against FSC-A. The full list of antibodies used can be found in table S4. Cell numbers per organ or per gram of tissue were calculated as follow. In E9.5 to E12.5 embryonic tissue cell suspensions were prepared, stained, and acquired from whole organs, and the number of live cells per tissue was directly obtained from FCS files. In E14.5 to E18.5 embryos, cells suspensions were prepared as above, but half were stained and acquired. In adult mice, organs were weighted, cell suspensions were prepared from 100 to 500 mg of tissues, and the number of live single F4/80 + cells per gram of tissue was determined using a cell counter (GUAVA easyCyte HT).
Cell sorting was performed using an Aria II BD cell sorter. Cell suspensions were prepared as above, except for the gating of single live cells which was performed using dead cell exclusion with DAPI. For bulk sequencing, EMPs were identified after gating on Kit sciencemag.org SCIENCE Fig. 8 . Graphic summary of the establishment of the core macrophage program and subsequent specification. Cx3cr1 is expressed in pMacs and is important for colonization of the embryo. Id3 is a liver macrophage-specific gene, which is essential for Kupffer cell development.
proper were sorted into 384-well plates filled with 2 ml lysis buffer (Triton-X 0.2%) (Sigma) in molecular biology grade H 2 O (Sigma) supplemented with 0.4 U/ml protein-based RNase inhibitor (Takara) and barcoded poly-T primers, and processed as described below (Generation and analysis of single-cell transcriptomes).
Cytology
Cells were collected into FCS and centrifuged (800 rpm, 10 min, low acceleration) onto Superfrost slides (Thermo Scientific) using a Cytospin 3 (Thermo Shandon). Slides were air-dried for at least 30 min, and fixed for 5 min in methanol, stained in 50% May-Grünwald solution for 5 min, 14% Giemsa for 15 min, washed with Sorensons buffered distilled water (pH 6.8) for 5 min and rinsed with Sorensons buffered distilled water (pH 6.8). Slides were air-dried and mounted with Entellan New (Merck) and representative pictures were taken using an Axio Lab.A1 microscope (Zeiss) under a N-Achroplan 100x/01.25 objective.
Immunofluorescence, imaging, analysis, and illustrations E10.25 Embryos were fixed for 4 hours in 4% formaldehyde (Sigma) under agitation and >E10.25 embryos were fixed overnight. After fixation, embryos were incubated overnight in 30% sucrose and embedded in OCT compound (Sakura Finetek).
Cryoblocks were cut at a thickness of 10-12 mm and then blocked with PBS containing 5% normal goat serum (Invitrogen); 1% BSA (w/v); 0.3% Triton X-100 for 1 hour at room temperature. Samples were incubated overnight at 4°C with rat anti- Samples were then mounted with Fluoromount mounting medium with DAPI (eBiosciences) and visualized using a LSM880 Zeiss microscope with 20x/0.5 (dry), performing a tile scan and Z-stack on whole embryos or tissues. Image analysis and cell quantification was performed using Imaris (Bitplane) software. To determine the CD31 + area in Id3 +/− and Id3 −/− liver sections, maximum intensity Z-projections pictures were converted into binary images and the CD31 + area was measured using Image J (NIH, Bethesda, MD, USA) (39). RNA from sorted cells was extracted using RNeasy mini kit (Qiagen) according to instructions provided by the manufacturer. After ribogreen quantification and quality control of Agilent BioAnalyzer, 400 pg of total RNA underwent amplification (12 cycles) using the SMART-seq V4 (Clonetech) ultra low input RNA kit for sequencing. 10 ng of amplified cDNA was used to prepare Illumina hiseq libraries with the Kapa DNA library preparation chemistry (Kapa Biosystems) using 8 cycles of PCR. Samples were barcoded and run on a Hiseq 2500 1T in a 50 bp/50 bp Paired end run, using the TruSeq SBS Kit v3 (Illumina). An average of 54 million paired reads were generated per sample and the percent of mRNA bases was closed to 77% on average. The output data (FASTQ files) were mapped to the target genome using the rnaStar aligner (40) that maps reads genomically and resolves reads across splice junctions. 2 pass mapping method was used, outlined in Engstrom et al. (41) in which the reads are mapped twice. The first mapping pass uses a list of known annotated junctions from Ensemble. Novel junctions found in the first pass are then added to the known junctions and a second mapping pass is done (on the second pass the RemoveNoncanoncial flag is used). After mapping we post process the output SAM files using the PICARD tools to: add read groups, AddOrReplaceReadGroups which in additional sorts the file and coverts it to the compressed BAM format. We then compute the expression count matrix from the mapped reads using HTSeq and one of several possible gene model databases.
The raw count matrix generated by HTSeq are then processed using the R/Bioconductor package DESeq, which was used to both normalize the full data set and analyze differential expression between sample groups. Gene Ontology analysis was performed using the GO analysis function in GeneSpring GX 13.0 (Agilent), with the P value calculated using a hypergeometric test with Benjamini-Yekutieli correction. For that, genes with a fold change difference of ±2 between Id3 +/− and Id3 −/− Kupffer cells were selected. Significantly regulated genes (t test P < 0.05; FDR < 0.05) from this selection were grouped into GO terms.
Generation and analysis of "bulk" transcriptomes from candidate EMP, pMac, and macrophage populations from E9 to P21 RNA isolation and library construction cDNA synthesis and enrichment was performed following the Smart-seq2 protocol as described (42, 43) . ERCC spike-in RNA (Ambion) was added to the lysis buffer in a final dilution of 1:1,000,000. After the cDNA was synthesized and amplified from single cells using 18 cycles, quantitative PCR was performed with GoTaq-PCR master mix (Promega) on a C1000 Touch Thermal Cycler qPCR instrument (Bio-Rad) to test for house keeping gene expression. Library preparation was conducted on 1ng of cDNA using the Nextera XT library preparation kit (Illumina) as described (43) . Sequencing was performed by the Biomedical Sequencing Facility at CeMM using a 50 bp singleread setup on the Illumina HiSeq 2500 platform.
RNA-seq analysis
We first trimmed off sequencing adapter from the reads generated, and then aligned the reads using Bowtie v 1.1.1 (44) (parameters: -q -p 6 -a -m 100 -minins 0 -maxins 5000 -fr -sam -chunkmbs 200) to the cDNA reference transcriptome (mm10 cDNA sequences from Ensembl). For genome browser track visualization, we generated a second alignment with Tophat2 (45) (v 2.0.13, parameters: -b2-L 15 -library-type fr-unstranded -mate-innerdist 150 -max-multihits 100 -no-coverage-search -GTF) against the reference genome (mm10). Next, we removed duplicate reads before quantifying transcript levels with BitSeq (46) (v 1.12.0). The raw transcript counts were loaded into R and processed further. At this stage, we removed samples with a substandard quality, that is, all samples that had less than 2 million reads, less than 33% of reads aligned, or less than 5,000 transcripts detected (with ≥ 25 reads). 20 out of 178 data sets failed these criteria (11.2%). Of the remaining data sets, we merged technical replicates creating 93 unique biological samples. We took forward only transcripts that were detected reliably (≥50 reads) in at least four samples (n = 37,521). For statistical analysis, we used raw read counts as input for DESeq2 (20) (21) . Briefly, we considered each list of differentially up-regulated genes as a set of marker genes and determined the relative enrichment of these marker sets in each individual condition (tissue by cell type by time) in comparison to all other data sets using a modified version of parametric gene set enrichment analysis in R (package: PGSEA). We also used GSEA to test for the relative overrepresentation of gene signatures in sorted gene lists. To this end, we extracted lists of genes sorted by logarithmic fold change between the mean expression levels in any one tissue Mac, pMac, or EMP sample stratified by stage (early = E9 to E10.5, fetal = E12.5 to E18.5, postnatal = P2 to P21) compared to all other samples at the same stage. Additionally, we extracted lists of all genes we found differentially up-regulated in any tissuespecific signature, cell type-specific signature, or in lists of genes extracted from (7, 25, 28) . External gene lists were translated to Ensembl Transcript IDs using g:profiler (49) . Both sets of data were loaded into and analyzed using the GSEA tool (50) and the results read and summarized using the metaGSEA R library. We also incorporated ChIP-seq binding profiles (bigWig) for factors identified in the LOLA analysis from the CODEX database. Heatmaps were generated using GeneSpring GX 13.0 (Agilent). All other analyses and plotting was performed in R.
Generation and analysis of single-cell transcriptomes
For single-cell RNA sequencing the MARS-Seq approach described by Jaitin et al. (51) RNA fragmentation solution (Ambion); 1.5 min at 70°C] followed by a 2 x SPRI bead (Beckman Coulter) cleanup. Barcoded ssDNA adapters [IDT; for barcode details see (51) were ligated to the fragmented RNA (9.5% DMSO (Sigma), 1 mM ATP, 20% PEG8000 and 1 U/ml T4 RNA ligase I (NEB) in 50 mM Tris HCl pH 7.5 (Sigma), 10 mM MgCl 2 and 1 mM DTT; 22°C for 2 hours) and a second RT reaction (Affinity Script RT buffer, 10 mM DTT, 4 mM dNTP, 2.5 U/ml Affinity Script RT enzyme (Agilent); 2 min at 42°C, 45 min at 50°C, 5 min at 85°C) was performed followed by a 1.5 x SPRI bead (Beckman Coulter) cleanup. Final libraries were generated by subsequent nested PCR reaction (0.5 mM of each Illumina primer [IDT; for primers details see (51) ] and KAPA HiFi HotStart ready mix (Kapa Biosystems) for 15 cycles according to manufacturer's protocol followed by a 0.7 x SPRI bead (Beckman Coulter) cleanup. Library quantity and quality were assessed using the Agilent 2200 Tapestation system and libraries were subjected to next generation sequencing using an Illumina HiSeq1500 instrument (PE with no index; read 1: 61 bases (3 bases random nucleotides, 4 bases pool barcode, 53 bases specific sequence), read 2: 13 bases [6 bases cell barcode, 6 bases unique molecular identifier)].
Preprocessing, quality assessment, and control of single-cell transcriptome data From sequenced data, pool barcodes, cell specific tags and Unique molecular identifiers (UMI) were extracted (576 cells sequenced). Subsequently, sequencing reads with ambiguous plate/cellspecific tags or UMI sequence with low quality (Phred < 27) and reads which map to E. coli were eliminated using Bowtie with parameters "-M 1 -t --best -chunkmbs 64 -strata." Next, fastq files were demultiplexed using the fastx_barcode_splitter from the fastx_toolkit and R1 reads (after trimming of pool barcode sequences) were mapped to the mouse mm10 and ERCC pseudo genome assembly using Bowtie "-m 1 -t -best -chunkmbs 64 -strata."
Valid reads were then counted using unique molecular identifiers if they mapped to the exon based gene model derived from Ensembl's biomart, mm10. Following this, a gene expression matrix was generated containing the number of unique UMIs associated with valid reads for every cell and every gene. Additionally, UMI sequencing errors were corrected for and filtered as described in (51) .
Filtering single-cell transcriptome data
In order to avoid biases introduced by low quality data we performed the following filtering of single-cell data. Removal of cells with a ratio of mitochondrial versus endogenous genes exceeding 0.15 and cells with less than 320 molecule counts or less than 150 unique genes were removed from the analysis. Prior to analysis expression tables were filtered for mitochondrial, ribosomal and predicted genes to reduce noise.
Analysis of MARS-seq single-cell transcriptome data
Analysis of the normalized and filtered singlecell gene expression data (8657 genes across 408 single-cell transcriptomes used in the final expression table) was done using several functions of the SEURAT single-cell analysis package (52) and Monocle 2 (53). First, highly variable genes were determined as genes exceeding the dispersion threshold of 0.75. To infer the structure of the gene expression data a PCA was performed on the basis of highly variable genes. Following tSNE DBScan clustering was performed to identify clusters of cells. The optimal number of clusters was identified by calculating several cluster indices by the NbClust R package (54) . Relative expression for a cell was calculated as gene expression of a gene/gene set in relation to the total molecule counts in this cell. To identify clusters within the MARS-seq data the relative gene expression profiles of cell type specific gene signatures were overlaid to the tSNE plots. Pseudotime analysis was performed by the Monocle 2 algorithm by genes exceeding the average expression cutoff of 1 while having an empirical dispersion higher than 1. To analyze expression of single genes, relative expression was overlaid onto the tSNE plots or visualized as dot plots.
Generation of cell signatures for analysis of single-cell data
In order to unambiguously identify cell state specific genes for EMPs, pMacs and early macrophages we generated exclusive gene signatures. Here, differentially expressed (DE) genes were identified by a one-way ANOVA model [|FC| > 1.4, FDR-adjusted P < 0.05 (55) ] between EMPs (E10.25 YS and fetal liver), pMacs (E10.25 YS, fetal liver, head, and limbs) and early macrophages (E10.25 and E10.5 YS, fetal liver, head, and limbs). The nonoverlapping DE genes between these three contrasts were chosen as exclusive gene signatures for further analysis.
Generation of tissue signatures for analysis of single-cell data
To identify genes that are up-regulated in tissue macrophages in relation to early macrophages a one-way ANOVA model [|FC| > 1.5, FDR-adjusted P < 0.05 (31)] was calculated. Up-regulated nonoverlapping DE genes between early macrophages (E10.25 and E10.5, fetal liver, head, and limbs/skin) versus brain macrophages (E14.5 and E18.5 brain), liver macrophages (E14.5 and E18.5 liver) or limb/skin macrophages (E14.5 and E18.5 limb/skin) were used as tissue macrophage specific gene signatures. Furthermore, a common early macrophage signature was defined as being up-regulated in early macrophages (E10.25 and E10.5 fetal liver, head, and limbs) versus all other late tissue macrophages (E14.5 and E18.5 liver, head, and limbs/skin). We assessed enrichment of these signatures in scRNA-seq data from pMacs by calculating an relative enrichment score for each signature in pMacs (molecule count of signature genes/(total molecule count × number of signature genes).
Enrichment of tissue signatures in scRNA-seq data
To assess enrichment of tissue macrophagespecific signatures or differentiation signatures in scRNA-seq data from pMacs, we identified genes with multimodal expression using Hartigan's Dip test statistic for unimodality. Next, multimodal genes were grouped by hierarchical clustering and enrichment of signatures within the clusters tested using hypergeometric testing with FDR correction (Benjamini-Hochberg).
